| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |